CorMedix Inc. — Director's Dealing 2026

Jan 27, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2026-01-23

Reporting Person: Zelnick Kaufman Beth (Chief Legal Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-23	Common Stock	A	72820	$0.00	Acquired	241905	Direct
2026-01-23	Common Stock	F	8803	$7.27	Disposed	233102	Direct

Footnotes

F1: These shares represent restricted stock units granted on 01/23/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.